Arcadia Biosciences Inc expected to post a loss of $6.80 a share - Earnings Preview

Arcadia Biosciences

28/03/2023 22:00

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 30. 
    * The Davis California-based  company is expected to report 
a
7.9% decrease in revenue to $2 million from $2.17 million a year
ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Arcadia Biosciences
Inc
is for a loss of $6.80 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $100​, above​ its last closing price
of $7.68. ​​​

This summary was machine generated March 28 at 21:00 GMT.  All
figures in US dollars  unless otherwise stated